To further support the findings observed in the CSNK2A1 knockdown cells, HeLa/DDP cells were treated with cisplatin, with or without CX‐4945, a potent and selective small molecule inhibitor of CK2, which exhibits strong anti‐tumor activity. The gene discussed is CSNK2A1; the disease is neoplasm.